GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Myrexis Inc (FRA:R9M) » Definitions » NonCurrent Deferred Liabilities

Myrexis (FRA:R9M) NonCurrent Deferred Liabilities : €0.00 Mil (As of Jun. 2013)


View and export this data going back to . Start your Free Trial

What is Myrexis NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Myrexis's non-current deferred liabilities for the quarter that ended in Jun. 2013 was €0.00 Mil.

Myrexis NonCurrent Deferred Liabilities Historical Data

The historical data trend for Myrexis's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Myrexis NonCurrent Deferred Liabilities Chart

Myrexis Annual Data
Trend Jun08 Jun09 Jun10 Jun11 Jun12 Jun13
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial - - - - -

Myrexis Quarterly Data
Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Myrexis NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of Myrexis's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Myrexis (FRA:R9M) Business Description

Traded in Other Exchanges
N/A
Address
630 Fifth Avenue, Suite 2260, New York, NY, USA, 10020
Myrexis Inc is engaged in evaluating strategic alternatives, such as identifying, evaluating and making financial investments in life sciences assets.

Myrexis (FRA:R9M) Headlines

No Headlines